BACKGROUND The standard treatment for endometrial carcinoma is staging laparotomy
with total abdominal hysterectomy and bilateral salpingo‐oophorectomy. In an attempt to …

BACKGROUND: To evaluate the efficacy and safety of long-term conservative therapy with
medroxyprogesterone acetate (MPA) for endometrial carcinoma in young patients who had …

Introduction: The purpose of this study was to evaluate the efficacy of conservative treatment
with progestin and pregnancy outcomes in women with early-stage endometrial cancer …

Four cases of clinical Stage I endometrial carcinoma initially treated with hormonal therapy
are included in this study. Three of them resulted in tumor regression and two of them …

OBJECTIVE: To evaluate the safety of fertility-sparing hormonal therapy for endometrial
cancer in young patients. METHODS: We reviewed the clinical and pathologic records of …

Objective: Our purpose was to assess the feasibility of using a progesterone-containing
intrauterine device (IUD) to treat presumed Federation Internationale Gynecologie et …

Progestational agents induced an objective response in 11.2% of 155 patients with
advanced primary or recurrent endometrial carcinoma. Response rates decreased with …

The data on 19 cases of primary endometrial carcinoma, stage I (mean age 28.0 years),
cured by the administration of hydroxyprogesterone caproate without surgery and radiation …

Background. Successful pregnancies after conservative progestin treatment to young
women with endometrial carcinoma have recently been reported. However, it is not known …

OBJECTIVE: We reviewed reported cases of grade 1 endometrial adenocarcinoma that
were conservatively managed with hormonal therapy in an effort to identify the most effective …